medlr news Zydus Enters Global Biologics CDMO Market with Strategic US Acquisition Zydus Lifesciences enters the global biologics CDMO space by acquiring two U.S. manufacturing sites from Agenus Inc., marking a major step in scaling biologics capabilities and driving innovation in immuno-oncology and advanced therapies.
medlr news Zydus Acquires 86% Stake in Amplitude Surgical: A Strategic Move in MedTech Zydus Lifesciences is set to acquire 86% of Amplitude Surgical, strengthening its presence in MedTech with innovative orthopedic solutions.
News Zydus Lifesciences Gains USFDA Approval for Generic Cancer Treatment Capsules Zydus Lifesciences secures USFDA nod for its Cyclophosphamide capsules, a crucial cancer treatment medication.
